Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth in vitro and in a murine model

被引:7
|
作者
Phan, Thuy [1 ]
Nguyen, Vu H. [2 ]
Su, Rui [3 ]
Li, Yangchan [3 ]
Qing, Ying [3 ]
Qin, Hanjun [4 ]
Cho, Hyejin [4 ]
Jiang, Lei [5 ]
Wu, Xiwei [4 ]
Chen, Jianjun [3 ]
Fakih, Marwan [6 ]
Diamond, Don J. [2 ]
Goel, Ajay [7 ]
Melstrom, Laleh G. [1 ]
机构
[1] City Hope Natl Med Ctr, Dept Surg, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Hematol, Duarte, CA USA
[3] City Hope Natl Med Ctr, Beckman Res Inst, Dept Syst Biol, Monrovia, CA USA
[4] City Hope Natl Med Ctr, Beckman Res Inst, Integrat Genom Core, Duarte, CA USA
[5] City Hope Natl Med Ctr, Dept Mol & Cellular Endocrinol, Duarte, CA USA
[6] City Hope Natl Med Ctr, Dept Med Oncol, Duarte, CA USA
[7] City Hope Natl Med Ctr, Dept Mol Diagnost & Expt Therapeut, Monrovia, CA USA
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
colorectal cancer; FTO; FTO inhibitor; RNA-seq; signaling pathways; NUCLEAR-RNA; CELL-CYCLE; PHASE-II; EXPRESSION; N6-METHYLADENOSINE; PROGRESSION; DEMETHYLASE; MECHANISMS; BISANTRENE; RESISTANCE;
D O I
10.3389/fonc.2023.1087644
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionColorectal cancer (CRC) remains a significant cause of cancer related mortality. Fat mass and obesity-associated protein (FTO) is a m6A mRNA demethylase that plays an oncogenic role in various malignancies. In this study we evaluated the role of FTO in CRC tumorigenesis. MethodsCell proliferation assays were conducted in 6 CRC cell lines with the FTO inhibitor CS1 (50-3200 nM) (+/- 5-FU 5-80 mM) and after lentivirus mediated FTO knockdown. Cell cycle and apoptosis assays were conducted in HCT116 cells (24 h and 48 h, 290 nM CS1). Western blot and m6A dot plot assays were performed to assess CS1 inhibition of cell cycle proteins and FTO demethylase activity. Migration and invasion assays of shFTO cells and CS1 treated cells were performed. An in vivo heterotopic model of HCT116 cells treated with CS1 or with FTO knockdown cells was performed. RNA-seq was performed on shFTO cells to assess which molecular and metabolic pathways were impacted. RT-PCR was conducted on select genes down-regulated by FTO knockdown. ResultsWe found that the FTO inhibitor, CS1 suppressed CRC cell proliferation in 6 colorectal cancer cell lines and in the 5-Fluorouracil resistant cell line (HCT116-5FUR). CS1 induced cell cycle arrest in the G2/M phase by down regulation of CDC25C and promoted apoptosis of HCT116 cells. CS1 suppressed in vivo tumor growth in the HCT116 heterotopic model (p< 0.05). Lentivirus knockdown of FTO in HCT116 cells (shFTO) mitigated in vivo tumor proliferation and in vitro demethylase activity, cell growth, migration and invasion compared to shScr controls (p< 0.01). RNA-seq of shFTO cells compared to shScr demonstrated down-regulation of pathways related to oxidative phosphorylation, MYC and Akt/ mTOR signaling pathways. DiscussionFurther work exploring the targeted pathways will elucidate precise downstream mechanisms that can potentially translate these findings to clinical trials.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Fat mass and obesity-associated protein regulates tumorigenesis of arecoline-promoted human oral carcinoma (vol 10, pg 6402, 2021)
    Li, X.
    Xie, X.
    Gu, Y.
    Zhang, J.
    Song, J.
    Cheng, X.
    Gao, Y.
    Ai, Y.
    CANCER MEDICINE, 2024, 13 (12):
  • [42] Estrogen promotes fat mass and obesity-associated protein nuclear localization and enhances endometrial cancer cell proliferation via the mTOR signaling pathway
    Zhu, Yaping
    Shen, Jiaqi
    Gao, Liyan
    Feng, Youji
    ONCOLOGY REPORTS, 2016, 35 (04) : 2391 - 2397
  • [43] Fat mass and obesity-associated protein (FTO) affects midpalatal suture bone remodeling during rapid maxillary expansion
    Zhao, Tingting
    Tao, Zhendong
    Zhang, Gengming
    Zhu, Jiaqi
    Du, Mingyuan
    Hua, Fang
    He, Hong
    EUROPEAN JOURNAL OF ORTHODONTICS, 2024, 46 (02)
  • [44] Effect of Pharmacological Inhibition of Fat-Mass and Obesity-Associated Protein on Nerve Trauma-Induced Pain Hypersensitivities
    Bi-Xin Zheng
    Xinying Guo
    Sfian Albik
    Jean Eloy
    Yuan-Xiang Tao
    Neurotherapeutics, 2021, 18 : 1995 - 2007
  • [45] Effect of Pharmacological Inhibition of Fat-Mass and Obesity-Associated Protein on Nerve Trauma-Induced Pain Hypersensitivities
    Zheng, Bi-Xin
    Guo, Xinying
    Albik, Sfian
    Eloy, Jean
    Tao, Yuan-Xiang
    NEUROTHERAPEUTICS, 2021, 18 (03) : 1995 - 2007
  • [46] The investigation of the effects of topiramate on the hypothalamic levels of fat mass/obesity-associated protein and neuropeptide Y in obese female rats
    Alkan, Isinsu
    Altunkaynak, Berrin Zuhal
    Altun, Gamze
    Erener, Erkan
    NUTRITIONAL NEUROSCIENCE, 2019, 22 (04) : 243 - 252
  • [47] The fat mass- and obesity-associated FTO gene is expressed in human placenta and is related to birth weight and placental visfatin
    Prats-Puig, Anna
    Bassols, Judit
    Vazquez-Ruiz, Montserrat
    Garcia-Gonzalez, Maria-Mar
    Giralt, Roser
    Palomer, Anna-Maria
    Juanola, Assumpcio
    Brossa, Assumpcio
    Mendoza-Dileo, Ericka
    Miranda-Arce, Miguel-Angel
    Fabrega, Roser
    Colomer-Virosta, Carme
    Villalon, Carme
    Ibanez, Lourdes
    Lopez-Bermejo, Abel
    HORMONE RESEARCH, 2009, 72 : 56 - 56
  • [48] The association between fat mass and obesity-associated (FTO) genotype and serum vitamin D level in breast cancer patients
    Gholamalizadeh, Maryam
    Mokhtari, Zohreh
    Doaei, Saeid
    Jalili, Vahideh
    Davoodi, Sayed Hossein
    Jonoush, Mona
    Akbari, Mohammad Esmail
    Hajipour, Azadeh
    Bahar, Bojlul
    Tabesh, Ghasem Azizi
    Omidi, Saeed
    Mosavi Jarrahi, Seyed Alireza
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (20) : 9627 - 9633
  • [49] Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case–control study in Japan
    Yingsong Lin
    Junko Ueda
    Kiyoko Yagyu
    Hiroshi Ishii
    Makoto Ueno
    Naoto Egawa
    Haruhisa Nakao
    Mitsuru Mori
    Keitaro Matsuo
    Shogo Kikuchi
    BMC Cancer, 13
  • [50] Weight Loss and/or Sulindac Mitigate Obesity-associated Transcriptome, Microbiome, and Protumor Effects in a Murine Model of Colon Cancer
    Bowers, Laura W.
    Glenny, Elaine M.
    Punjala, Arunima
    Lanman, Nadia A.
    Goldbaum, Audrey
    Himbert, Caroline
    Montgomery, Stephanie A.
    Yang, Peiying
    Roper, Jatin
    Ulrich, Cornelia M.
    Dannenberg, Andrew J.
    Coleman, Michael F.
    Hursting, Stephen D.
    CANCER PREVENTION RESEARCH, 2022, 15 (08) : 481 - 495